Stocks Decline on Celebrex Announcement
478003
Stocks dropped in very heavy trading Friday as fresh concerns about pharmaceuticals, coming after Pfizer Inc. announced a troublesome health study of its Celebrex drug, overshadowed news of subdued growth in consumer prices and inflation.
301330
New prescriptions for Pfizer Inc.&#39;s arthritis drug Celebrex fell 56 percent last week after the company released data showing the drug may increase the risk of heart attacks and strokes, according to Verispan, a market research company
584588
Stocks dropped on Friday as investors tempered their optimism that the economy could avoid recession, and locked in profits on banking and pharmaceutical shares after two days of sharp gains.
400237
U.S. stocks declined on Tuesday as  health insurers' shares fell, offsetting better-than-expected  earnings from tech bellwether IBM Corp. IBM.N and lower oil  prices.
732193
* The world&#39;s biggest drug company loses $25 billion in market value in one day as investors fear another Vioxx debacle. NEW YORK - Pfizer Inc.
172863
US stocks futures tumbled on Thursday after drug company Merck &amp; Co. (MRK.N: Quote, Profile, Research) announced it was recalling a key drug, indicating the market would open lower.
262153
Stocks fell on Monday as investors fretted about the U.S. economy's health and fears about a global slowdown mounted.
675217
U.S. blue chips fell on Thursday after  drug company Merck & Co.MRK.N said it was withdrawing its key  arthritis drug Vioxx, while relentless oil prices floated back  to $50 a barrel.
202222
Stocks were little changed on Friday,  recovering after a sharp early drop on news from Pfizer Inc.  PFE.N that patients in a study showed an increased risk of  heart attacks after taking its popular Celebrex drug.
467183
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...
764330
U.S. stock futures pointed to a  slightly lower open on Tuesday as investors take a step back  after last week's three-day rally, with shares of drug maker  Merck & Co. MRK.N under pressure as regulators step up  investigations into the company's withdrawal of its pain  reliever, Vioxx.
384336
Drug makers failed to bounce back from a Thursday slide, with many drug stocks closing down Friday as drug giant Pfizer Inc. and generic drug challenger Alpharma Inc.
632359
Shares of Atherogenics Inc. opened down 7.2 percent on the Nasdaq Wednesday following a pre-market report that the drug developer is abandoning further clinical trials of its AGIX-4207 treatment for rheumatoid arthritis.
114185
Shares drop as U.S. regulators say they want more info before approving caner medication Bonefos.
106101
U.S. stocks edged lower on Thursday,   dragged down by drug store shares after Wal-Mart Stores Inc.   WMT.N announced it was slashing prices of generic drugs in   Florida.
599967
New prescriptions for Pfizer Inc.'s  arthritis drug Celebrex fell 56 percent last week after the  company released data showing the drug may increase the risk of  heart attacks and strokes, the Wall Street Journal said.
619354
U.S. stocks were knocked lower on  Thursday after drug maker Merck & Co.MRK.N, a member of the  blue-chip Dow, recalled its widely sold Vioxx arthritis drug  and oil resumed its climb to $50 a barrel.